We are live on ! Find out more
TCM

Tao Capital Management Portfolio holdings

AUM $119M
1-Year Est. Return 87.46%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+87.46%
3 Year Est. Return
+356.21%
5 Year Est. Return
+280.73%
10 Year Est. Return
AUM
$116M
AUM Growth
-$16M
Cap. Flow
-$17.8M
Cap. Flow %
-15.32%
Top 10 Hldgs %
100%
Holding
10
New
Increased
Reduced
2
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$10.2M
2
OUST icon
Ouster
OUST
+$7.4M
3
SOND
Sonder
SOND
+$102K
4
DNA icon
Ginkgo Bioworks
DNA
+$82.9K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 43.05%
2 Healthcare 41.21%
3 Technology 15.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
1
Tesla
TSLA
$1.24T
$38.8M 33.39%
86,250
TWST icon
2
Twist Bioscience
TWST
$5.62B
$26.3M 22.63%
828,815
OUST icon
3
Ouster
OUST
$2.29B
$18.3M 15.75%
845,316
-280,000
-25% -$7.4M
MDGL icon
4
Madrigal Pharmaceuticals
MDGL
$12.6B
$12.2M 10.53%
21,000
-20,000
-49% -$10.2M
H icon
5
Hyatt Hotels
H
$17.6B
$11.2M 9.66%
70,000
TXG icon
6
10x Genomics
TXG
$5.87B
$3.44M 2.96%
210,862
MASS icon
7
908 Devices
MASS
$293M
$2.99M 2.57%
568,981
WRBY icon
8
Warby Parker
WRBY
$3.01B
$2.93M 2.52%
134,473
DNA icon
9
Ginkgo Bioworks
DNA
$481M
-5,683
Closed -$82.9K
SOND
10
DELISTED
Sonder
SOND
-80,188
Closed -$102K

Similar funds

Tao Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Tao Capital Management held 10 positions worth $116M, down 12% from $132M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tao Capital Management withdrew a net $17.8M in Q4 2025, closing 2 positions and reducing 2 holdings. Its most notable exit was Sonder, an estimated $102K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 43% of assets, up from 37% a quarter earlier, followed by Healthcare and Technology.

  • Tao Capital Management's biggest Q4 2025 reduction was Madrigal Pharmaceuticals, cutting an estimated $10.2M.
  • Tao Capital Management fully exited Sonder in Q4 2025, selling an estimated $102K.
  • Tao Capital Management's ten largest holdings make up 100% of its $116M portfolio in Q4 2025.
  • Tao Capital Management opened 0 new positions and closed 2 in Q4 2025.
  • Tao Capital Management's portfolio value fell 12% quarter-over-quarter to $116M.

Based on Tao Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.